vs

Side-by-side financial comparison of NATURAL RESOURCE PARTNERS LP (NRP) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $51.3M, roughly 1.4× NATURAL RESOURCE PARTNERS LP). NATURAL RESOURCE PARTNERS LP runs the higher net margin — 78.5% vs -49.0%, a 127.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -21.8%).

Natural Resource Partners LP is a U.S.-headquartered master limited partnership that owns, manages and leases mineral reserve interests. Its asset portfolio covers coal, aggregates, industrial minerals and oil & gas, with operations primarily across North America, deriving most revenue from royalties paid by third-party resource extraction operators.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

NRP vs VRDN — Head-to-Head

Bigger by revenue
VRDN
VRDN
1.4× larger
VRDN
$70.6M
$51.3M
NRP
Growing faster (revenue YoY)
VRDN
VRDN
+81980.0% gap
VRDN
81958.1%
-21.8%
NRP
Higher net margin
NRP
NRP
127.6% more per $
NRP
78.5%
-49.0%
VRDN

Income Statement — Q1 FY2025 vs Q3 FY2025

Metric
NRP
NRP
VRDN
VRDN
Revenue
$51.3M
$70.6M
Net Profit
$40.3M
$-34.6M
Gross Margin
Operating Margin
83.7%
-56.7%
Net Margin
78.5%
-49.0%
Revenue YoY
-21.8%
81958.1%
Net Profit YoY
-28.4%
54.9%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRP
NRP
VRDN
VRDN
Q3 25
$70.6M
Q1 25
$51.3M
Q4 24
$61.8M
Q3 24
$50.4M
Q2 24
$54.6M
Q1 24
$65.6M
Q4 23
$72.9M
Q3 23
$68.5M
Net Profit
NRP
NRP
VRDN
VRDN
Q3 25
$-34.6M
Q1 25
$40.3M
Q4 24
$42.8M
Q3 24
$38.6M
Q2 24
$46.1M
Q1 24
$56.2M
Q4 23
$65.0M
Q3 23
$63.8M
Operating Margin
NRP
NRP
VRDN
VRDN
Q3 25
-56.7%
Q1 25
83.7%
Q4 24
74.9%
Q3 24
84.9%
Q2 24
92.3%
Q1 24
91.0%
Q4 23
94.5%
Q3 23
98.8%
Net Margin
NRP
NRP
VRDN
VRDN
Q3 25
-49.0%
Q1 25
78.5%
Q4 24
69.2%
Q3 24
76.6%
Q2 24
84.4%
Q1 24
85.7%
Q4 23
89.1%
Q3 23
93.2%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRP
NRP
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$30.9M
$490.9M
Total DebtLower is stronger
$138.8M
Stockholders' EquityBook value
$503.0M
Total Assets
$772.5M
$577.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRP
NRP
VRDN
VRDN
Q3 25
$490.9M
Q1 25
$30.9M
Q4 24
$30.4M
Q3 24
$30.9M
Q2 24
$32.3M
Q1 24
$11.0M
Q4 23
$12.0M
Q3 23
$18.4M
Total Debt
NRP
NRP
VRDN
VRDN
Q3 25
Q1 25
$138.8M
Q4 24
$142.1M
Q3 24
$197.4M
Q2 24
$210.3M
Q1 24
$188.8M
Q4 23
$155.1M
Q3 23
$207.5M
Stockholders' Equity
NRP
NRP
VRDN
VRDN
Q3 25
$503.0M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Total Assets
NRP
NRP
VRDN
VRDN
Q3 25
$577.1M
Q1 25
$772.5M
Q4 24
$772.9M
Q3 24
$772.9M
Q2 24
$789.6M
Q1 24
$772.9M
Q4 23
$797.9M
Q3 23
$815.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRP
NRP
VRDN
VRDN
Operating Cash FlowLast quarter
$34.4M
$-84.6M
Free Cash FlowOCF − Capex
$-84.7M
FCF MarginFCF / Revenue
-120.1%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRP
NRP
VRDN
VRDN
Q3 25
$-84.6M
Q1 25
$34.4M
Q4 24
$66.2M
Q3 24
$54.1M
Q2 24
$56.6M
Q1 24
$71.5M
Q4 23
$77.8M
Q3 23
$78.9M
Free Cash Flow
NRP
NRP
VRDN
VRDN
Q3 25
$-84.7M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
FCF Margin
NRP
NRP
VRDN
VRDN
Q3 25
-120.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Q3 23
Capex Intensity
NRP
NRP
VRDN
VRDN
Q3 25
0.2%
Q1 25
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Q4 23
0.0%
Q3 23
0.0%
Cash Conversion
NRP
NRP
VRDN
VRDN
Q3 25
Q1 25
0.86×
Q4 24
1.55×
Q3 24
1.40×
Q2 24
1.23×
Q1 24
1.27×
Q4 23
1.20×
Q3 23
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NRP
NRP

Coal Royalty Revenues$35.5M69%
Soda Ash Segment$4.6M9%
Transportation And Processing Services$4.4M9%
Production Lease Minimum Revenues$2.7M5%
Oil And Gas Royalty Revenues$2.4M5%
Other$1.6M3%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons